Revel Pharmaceuticals
revelpharmaceuticals.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$7.1M
3 rounds on record
Latest round
$5.8M
Venture round · Feb 2022 · 4 yr ago
Team
6
US Form 5500 (plan participants) · Dec 2025 · -14% in a year
The money's age
Long since its last round
55 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 23, 2022
Raised a round Venture round $5.8M · SEC Form D
Mar 24, 2021
Raised a round Venture round $800k · SEC Form D
Dec 20, 2019
Raised a round Venture round $533k · SEC Form D
2019
Founded
Tractionpublic signals, read monthly
Hacker News stories
1
best: 2 points
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2022 | $5.8M | — | SEC Form D |
| Venture round | Mar 2021 | $800k | — | SEC Form D |
| Venture round | Dec 2019 | $533k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Revel Pharmaceuticals Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Aaron CravensExecutive Officer, DirectorSEC Form D
Similar startupsby what they do, their industry and backers
A gene therapy approach to treating chronic, age-related disease. Targeting the root causes of aging to create life-changing treatments for…
We are on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases.
Targetingcellular stressRevolutionizingmedicine. At Neurodon, we treat cellular stress at the root of many diseases; we create…
Pando uses AI enzyme design and enzyme engineering to discover high-performance DNA polymerase tools, including Phi29 enzymes for molecular…
Transforming Eye Care With Precision Medicine. Age-related macular degeneration (AMD) impacts one in eight people over the age of fifty and…
Unlock the secrets of your genetics to rejuvenate your body. Our advanced analysis dives deep into your DNA, unveiling targeted strategies…
News
Revel Pharmaceuticals and Collaborators Report Enzymatic Reversal of a Chemical Hallmark of Aging in Human Tissue
Revel Pharmaceuticals and Collaborators Report Enzymatic Reversal of a Chemical Hallmark of Aging in Human Tissue
Read more
Report
People
Aaron Cravens
Executive Officer, Director
Jennifer Cochran
Director
Patrick Burgermeister
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
10-50 est. staff